Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

YOU WONT BELIEVE: 7 | Mind Blowing Facts

DYAI: Don't Put All Your Eggs in One Basket

By John Vandermosten, CFA NASDAQ:DYAI READ THE FULL DYAI RESEARCH REPORT

Benzinga

XTMIF: How Can Customers Say No to XTM's Digital Employee Payout Solution When It's Free?

By Lisa Thompson OTC:XTMIF READ THE FULL XTMIF RESEARCH REPORT

Benzinga

CPKF: Record Earnings in 2022

By Ann Heffron, CFA, CPA OTC:CPKF READ THE FULL CPKF RESEARCH REPORT

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

EDSA: Phase 3 Trial of EB05 Hits 25% Enrollment…

By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT

Benzinga

TSEM: Intel Strikes Deal to Buy Tower Semiconductor for $53 Per Share

By Lisa Thompson NASDAQ:TSEM READ THE FULL TSEM RESEARCH REPORT

Benzinga

ALVOF: Alvopetro Energy's Organic Growth Plan Continues to be Successfully Executed. Production continues to grow and contract pricing significantly increased effective February 1st.

By Steven Ralston, CFA OTC:ALVOF | TSX:ALV.V READ THE FULL ALVOF RESEARCH REPORT

Benzinga

ATE.TO: First Human PK/PD Studies Underway in Otenaproxesul's Post-Operative Pain Program…

By David Bautz, PhD OTC:ATBPF | TSX:ATE.TO READ THE FULL ATE.TO RESEARCH REPORT

Benzinga

Read news from The Economist, FT, and more,
with one subscription

UHAL: AMERCO reports another strong quarter with revenues above expectations. Adjusted for seasonality of the company's businesses, UHAL continues to experience robust demand and strong pricing in the current environment.

By Steven Ralston, CFA NASDAQ:UHAL READ THE FULL UHAL RESEARCH REPORT

Benzinga

CXW: Expect Improvements to Continue in 2022; Believe New Contract Underscores Need for CXW's Modern Facilities

By M. Marin NYSE:CXW READ THE FULL CXW RESEARCH REPORT

Benzinga

EEIQ: Optimistic About New Pathways Model, O&O Initiative, Other Growth Plans

By M. Marin NASDAQ:EEIQ READ THE FULL EEIQ RESEARCH REPORT Expanding in key markets

Benzinga

BTCY: Initiating Coverage – Outpatient Remote Cardiac Health Monitoring & Ecosystem with Emerging Growth Company Profile

By T. Moore, CFA NASDAQ:BTCY READ THE FULL BTCY RESEARCH REPORT

Benzinga

NVX: Kore Power Deal Positive, As NVX Ramps Production; EV Charging Infrastructure Growing Rapidly

By M. Marin NASDAQ:NVX READ THE FULL NVX RESEARCH REPORT

Benzinga

BVXV: Building a Pipeline of VHH Antibody Drug Candidates…

By David Bautz, PhD NASDAQ:BVXV READ THE FULL BVXV RESEARCH REPORT

Benzinga

MHH: Mastech Digital Reports 2021 Revenue Growth of 14% to $222 Million Despite Pandemic Challenges

By Lisa Thompson NYSE:MHH READ THE FULL MHH RESEARCH REPORT

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

UCASU: Diversification into agriculture properties continues

By Beth Senko, CFA OTC:UCASU READ THE FULL UCASU RESEARCH REPORT

Benzinga

SQZ: IND Cleared for Enhanced APCs

By John Vandermosten, CFA NYSE:SQZ READ THE FULL SQZ RESEARCH REPORT

Benzinga

SBEV: Beverage Player With Expanding Brand Portfolio, Strong Distribution Network & Growth Strategy

By M. Marin NYSE:SBEV PRODUCT PORTFOLIO

Benzinga

EPIX: First Patient Dosed in Combination Trial of EPI-7386 and Enzalutamide…

By David Bautz, PhD NASDAQ:EPIX READ THE FULL EPIX RESEARCH REPORT

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

ACHV: The Final Phase III Begins

By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT

Benzinga

VIVXF: More Favorable Business Conditions Likely in 2022…

By David Bautz, PhD OTC:VIVXF READ THE FULL VIVXF RESEARCH REPORT

Benzinga

BICX: Pandemic surge leads to worsening trend in opioid deaths

By Beth Senko, CFA OTC:BICX READ THE FULL BICX RESEARCH REPORT

Benzinga

BIOAF: Third Quarter Results

By John Vandermosten, CFA OTC:BIOAF READ THE FULL BIOAF RESEARCH REPORT

Benzinga

BLRX: Initiating on BioLineRx: Mobilizing the Troops with Motixafortide

By John Vandermosten, CFA NASDAQ:BLRX READ THE FULL BLRX RESEARCH REPORT

Benzinga

OIIM: Q4 Revenues Were Hurt By Now-Resolved Production Issues for Wafers

By Lisa Thompson NASDAQ:OIIM READ THE FULL OIIM RESEARCH REPORT

Benzinga

RFHRF: Renforth Resources is advancing two high-priority mining projects: the Parbec Gold Project and the Surimeau District Property.

By Steven Ralston, CFA OTC:RFHRF | CSE:RFR READ THE FULL RFHRF RESEARCH REPORT

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.